So far, there is growing evidence indicating that over-expression of SLC7A11 is a hallmark of various cancer aspects, such as tumorigenesis, proliferation, metastasis, prognosis and resistance to chemotherapy [6]. This evidence concerns the gene SLC7A11 and cancer.